Skip to main content
Screener/Healthcare/Drug Manufacturers - Specialty & Generic

ESPR Esperion Therapeutics, Inc.

NASDAQ
$3.150.00 (0.00%)
$0.69
$4.17
$3.14
$3.15
EPS (TTM)$-0.17
P/E Ratio-19.93
Dividend Yield
Market Cap$648.7M
Volume6.15M
Prev Close$3.14
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$168.4M$61.8M$0.2283.5%36.7%
Q3 '25$87.3M-$31.3M$-0.1636.5%-35.9%
Q2 '25$82.4M-$12.7M$-0.0265.4%-15.4%
Q1 '25$65.0M-$40.5M$-0.2151.5%-62.2%
Q4 '24$69.1M-$21.3M$-0.1162.9%-30.8%
Q3 '24$51.6M-$29.5M$-0.1566.5%-57.2%
Q2 '24$73.8M-$61.9M$-0.3378.9%-83.9%
Q1 '24$137.7M$61.0M$0.3492.7%44.3%
Get Your Daily Market Recap